Oric Pharmaceuticals
D

ORIC

7.84500
USD
-0.64
(-7.54%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
42,677
الربح لكل سهم
-2
العائد الربحي
-
P/E
-6
حجم السوق
813,155,086
أصول ذات صلة

العنوان: Oric Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

أسئلة شائعة حول سهم Oric Pharmaceuticals